ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO230

Erythrocytapheresis in the Management of Acute Sodium Nitrate Toxicity

Session Information

  • Pharmacology
    November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pharmacology (PharmacoKinetics‚ -Dynamics‚ -Genomics)

  • 1900 Pharmacology (PharmacoKinetics‚ -Dynamics‚ -Genomics)

Authors

  • Ha, Nam, UVA Health, Charlottesville, Virginia, United States
  • Hughes, Parker K., UVA Health, Charlottesville, Virginia, United States
  • Kumar, Anubhav, UVA Health, Charlottesville, Virginia, United States
Introduction

Sodium nitrate, a common food preservative, is increasingly implicated in suicide attempts. Nitrate oxidizes hemoglobin to methemoglobin, which has poor oxygen-binding capacity. At high concentrations, methemoglobinemia leads to cardiovascular collapse. We present a case of life-threatening methemoglobinemia following intentional sodium nitrate ingestion requiring erythrocytapheresis (RBC exchange) and arteriovenous extracorporeal membrane oxygenation (VA ECMO).

Case Description

A 27-year-old woman with a history of depression reported to emergency services that she had injected sodium nitrate into her abdomen. On arrival to the emergency department, she was unresponsive, cyanotic, hypotensive, and hypoxic to oxygen saturation of 75%. Methemoglobin level was 86%. She was given methylene blue, intubated with succinylcholine and started on vasopressor and ascorbic acid. Nephrology was consulted for RBC exchange and cardiothoracic surgery for possible serotonin syndrome after methylene blue administration. Patient underwent cannulation to begin VA ECMO. RBC exchange was begun via the ECMO circuit; 2200 mL of red cell volume was exchanged, and methemoglobin level decreased to 5.6%. The patient required no further apheresis therapy and was later decannulated from VA ECMO the next day and eventually transferred for psychiatric care.

Discussion

Sodium nitrate ingestion induces cardiovascular collapse via smooth muscle relaxation, compromising venous return. Methemoglobin production occurs via nitrate-mediated oxidation of hemoglobin’s ferrous moiety to ferric, impairing oxygen binding and producing hypoxia. Methylene blue may be helpful to reduce ferric iron to ferrous but may be inadequate on its own in cases of extreme poisoning or cardiorespiratory symptoms. Rapid initiation of erythrocytaphresis may be life-saving in these situations, as observed in this case.